FOLH1 and neuroendocrine neoplasm: There is limited evidence about the expression of [68Ga]Ga-PSMA in neuroendocrine tumors, typically characterized by an increased neovascularization, which also expresses the prostate transmembrane glycoprotein (PSMA).